Purdue Pharma Could Face Problem With Bankruptcy As Profits Lined Its Owners’ Pockets

OxyContin manufacturer Purdue Pharma is reportedly weighing a bankruptcy filing after most of its profits ended up in the pockets of the Sacklers, the multibillion-dollar family who control the company, according to sources cited by The Wall Street Journal.

The drug company is working with restructuring experts for a potential bankruptcy filing, people familiar with the matter said, Reuters first reported Monday.

Sackler family members, including former president Richard Sackler, own the company through trusts and controlled its board for years, according to TheWSJ. Now Purdue Pharma’s assets may not be enough to cover its potential liability in lawsuits brought by roughly 1,600 cities, counties and states.

(Article Continues Below Advertisement)

OxyContin was Purdue Pharma’s largest revenue stream with $35 billion in sales between 1995 and 2015. It helped make the Sacklers the 19th-richest family in the U.S. with an estimated $13 billion net worth, according to Forbes. A 2017 TheDCNF investigation found no evidence the Sackler family was using its vast personal wealth to help recovering opioid addicts.

If Purdue Pharma files for Chapter 11 protection, the litigation against it would be halted and the drug company could negotiate with plaintiffs under a U.S. bankruptcy judge’s supervision, reported Reuters.

Other companies including USA Gymnastics, facing a scandal with former team doctor Larry Nassar, and California’s utility PG&E Corp. have filed for bankruptcy protection to cope with potential liability, reported TheWSJ.

Right now, Purdue and other companies involved in multidistrict litigation, meaning they’re in settlement talks overseen by Ohio U.S. District Judge Dan Polster. The talks deal with hundreds of opioid-related lawsuits filed in federal court, reported TheWSJ. Thirty-six states including Oklahoma and Massachusetts have sued Purdue outside of the multidistrict litigation.

Her remark was likely targeted at a previously unseen email from Richard Sackler, then-president of Purdue Pharma. Many communications by company executives were revealed in January in a 312-page filing by Healey’s office.

“[W]e have to hammer on abusers in every way possible,” Sackler wrote in a 2001 email quoted in the filing. “They are the culprits and the problem. They are reckless criminals.”

Content created by The Daily Caller News Foundation is available without charge to any eligible news publisher that can provide a large audience. For licensing opportunities of our original content, please contact [email protected]